Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

1.

Clonidine treatment of hyperactive and impulsive children with autistic disorder.

Jaselskis CA, Cook EH Jr, Fletcher KE, Leventhal BL.

J Clin Psychopharmacol. 1992 Oct;12(5):322-7.

PMID:
1479049
[PubMed - indexed for MEDLINE]
2.

Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.

Niederhofer H, Staffen W, Mair A.

Hum Psychopharmacol. 2003 Jul;18(5):389-93.

PMID:
12858327
[PubMed - indexed for MEDLINE]
3.

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.

Fankhauser MP, Karumanchi VC, German ML, Yates A, Karumanchi SD.

J Clin Psychiatry. 1992 Mar;53(3):77-82.

PMID:
1548248
[PubMed - indexed for MEDLINE]
4.

Use of clonidine in children with autism spectrum disorders.

Ming X, Gordon E, Kang N, Wagner GC.

Brain Dev. 2008 Aug;30(7):454-60. doi: 10.1016/j.braindev.2007.12.007. Epub 2008 Feb 15.

PMID:
18280681
[PubMed - indexed for MEDLINE]
5.

St John's Wort treating patients with autistic disorder.

Niederhofer H.

Phytother Res. 2009 Nov;23(11):1521-3. doi: 10.1002/ptr.2580.

PMID:
19274686
[PubMed - indexed for MEDLINE]
6.

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

Handen BL, Johnson CR, Lubetsky M.

J Autism Dev Disord. 2000 Jun;30(3):245-55.

PMID:
11055460
[PubMed - indexed for MEDLINE]
7.

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Research Units on Pediatric Psychopharmacology Autism Network.

Arch Gen Psychiatry. 2005 Nov;62(11):1266-74.

PMID:
16275814
[PubMed - indexed for MEDLINE]
8.

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff S, Shah BG, Snape M, Shernoff EW, Williamson K, Cook EH Jr.

J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):658-65.

PMID:
11392343
[PubMed - indexed for MEDLINE]
9.

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

Gordon CT, State RC, Nelson JE, Hamburger SD, Rapoport JL.

Arch Gen Psychiatry. 1993 Jun;50(6):441-7.

PMID:
8498878
[PubMed - indexed for MEDLINE]
10.

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E.

Int Clin Psychopharmacol. 2006 Nov;21(6):363-7.

PMID:
17012983
[PubMed - indexed for MEDLINE]
11.

A prospective, open-label trial of galantamine in autistic disorder.

Nicolson R, Craven-Thuss B, Smith J.

J Child Adolesc Psychopharmacol. 2006 Oct;16(5):621-9.

PMID:
17069550
[PubMed - indexed for MEDLINE]
12.

Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.

Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG, Daviss WB, McDermott MP.

J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):180-8. doi: 10.1097/chi.0b013e31815d9af7.

PMID:
18182963
[PubMed - indexed for MEDLINE]
13.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
[PubMed - indexed for MEDLINE]
14.

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.

Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD.

Pediatrics. 2001 Jun;107(6):E105.

PMID:
11389303
[PubMed - indexed for MEDLINE]
15.

Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children.

Biederman J, Gao H, Rogers AK, Spencer TJ.

Biol Psychiatry. 2006 Nov 15;60(10):1106-10. Epub 2006 Jun 27.

PMID:
16806096
[PubMed - indexed for MEDLINE]
16.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
[PubMed - indexed for MEDLINE]
17.

Guanfacine in children with autism and/or intellectual disabilities.

Handen BL, Sahl R, Hardan AY.

J Dev Behav Pediatr. 2008 Aug;29(4):303-8. doi: 10.1097/DBP.0b013e3181739b9d.

PMID:
18552703
[PubMed - indexed for MEDLINE]
18.

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A, Weller RA, Khayrallah M, Ascher J.

J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1314-21.

PMID:
8885585
[PubMed - indexed for MEDLINE]
19.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
[PubMed - indexed for MEDLINE]
20.

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.

Child Care Health Dev. 2006 Sep;32(5):575-83.

PMID:
16919137
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk